Theralink Technologies, Inc. (THER)
0.0000
0.00 (0.00%)
USD |
OTCM |
Jun 29, 16:00
Theralink Technologies Cash from Investing (TTM)
Cash from Investing (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Investing (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | -0.1554M |
| September 30, 2023 | -0.1634M |
| June 30, 2023 | -0.0514M |
| March 31, 2023 | -0.1349M |
| December 31, 2022 | -0.1396M |
| September 30, 2022 | -0.1316M |
| June 30, 2022 | -0.1068M |
| March 31, 2022 | -0.0403M |
| December 31, 2021 | -0.046M |
| September 30, 2021 | -0.1342M |
| June 30, 2021 | -0.1515M |
| March 31, 2021 | |
| December 31, 2020 | |
| September 30, 2020 | |
| June 30, 2020 | |
| March 31, 2020 | |
| December 31, 2019 | 0.00 |
| September 30, 2019 | 0.00 |
| June 30, 2019 | 0.00 |
| March 31, 2019 | 0.00 |
| December 31, 2018 | 0.00 |
| September 30, 2018 | |
| June 30, 2018 | |
| March 31, 2018 | |
| December 31, 2017 |
| Date | Value |
|---|---|
| September 30, 2017 | -0.0116M |
| June 30, 2017 | -0.0116M |
| March 31, 2017 | |
| December 31, 2016 | |
| September 30, 2016 | |
| June 30, 2016 | |
| May 31, 2016 | |
| February 29, 2016 | |
| November 30, 2015 | |
| August 31, 2015 | |
| May 31, 2015 | |
| February 28, 2015 | |
| November 30, 2014 | |
| August 31, 2014 | -0.0017M |
| May 31, 2014 | -0.0773M |
| February 28, 2014 | -0.1523M |
| November 30, 2013 | 0.4197M |
| August 31, 2013 | 0.7414M |
| May 31, 2013 | 0.817M |
| February 28, 2013 | 0.892M |
| November 30, 2012 | 0.1884M |
| August 31, 2012 | 0.0649M |
| May 31, 2012 | 0.0649M |
| February 29, 2012 | 0.0649M |
| November 30, 2011 | 0.01M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (TTM) Benchmarks
| Myriad Genetics, Inc. | -25.60M |
| BioRestorative Therapies, Inc. | 7.499M |
| Nanobac Pharmaceuticals, Inc. | -- |
| Biocept, Inc. | -- |
| CareDx, Inc. | 11.89M |